Clinical trial
Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar…
NCT00485771 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00485771 |
|---|---|
| Title | Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression |
| Official title | Olanzapine/Fluoxetine Combination Versus Lamotrigine in the Treatment of Bipolar I Depression |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Olanzapine, Fluoxetine, Lamotrigine |
| Enrollment | 403 |
| Start date | Nov 1, 2003 |
| Completion | Jan 1, 2005 |
| First posted | Jun 13, 2007 |
| Last update posted | Jun 13, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: